Compare $ENSC vs $INTS | Chartloom

Compare

$ENSC vs $INTS

Ensysce Biosciences Inc · Intensity Therapeutics Inc

ENSC

Ensysce Biosciences Inc

INTS

Intensity Therapeutics Inc

Compare $ENSC vs $INTS

Comparing Ensysce Biosciences Inc and Intensity Therapeutics Inc

ENSCEnsysce Biosciences Inc

INTSIntensity Therapeutics Inc

ENSCEnsysce Biosciences Inc

Market cap

$8M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-39.3%

YTD performance

-43.9%

52W performance

-78.6%

FCF yield

-116.0%

INTSIntensity Therapeutics Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-64.3%

52W performance

-49.1%

FCF yield

-91.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ENSC

INTS

Detailed metrics comparison

ENSC

Ensysce Biosciences Inc

INTS

Intensity Therapeutics Inc

Market Cap

ENSC$8M

INTS$10M

Enterprise Value

ENSC$7M

INTS$272K

Price

ENSC$0.53

INTS$3.63

P/E Ratio

ENSCN/A

INTSN/A

P/S Ratio

ENSC1.72x

INTS0.00x

EV/Sales

ENSC1.61x

INTS0.00x

EV/EBITDA

ENSC0.00x

INTS0.00x

P/B Ratio

ENSC2.39x

INTS1.22x

P/FCF Ratio

ENSCN/A

INTSN/A

EV/FCF

ENSC-0.81x

INTS-0.03x

PEG Ratio

ENSCN/A

INTSN/A

Forward P/E (NTM)

ENSCN/A

INTSN/A

Forward P/S (NTM)

ENSCN/A

INTSN/A

Revenue (TTM)

ENSC$5M

INTS$0

Revenue Growth (YoY)

ENSC-39.3%

INTSN/A

Forward Rev Growth

ENSC-45.7%

INTS506.0%

Gross Margin (TTM)

ENSC0.0%

INTS0.0%

Operating Margin (TTM)

ENSC0.0%

INTS0.0%

EBITDA Margin (TTM)

ENSC-197.8%

INTS0.0%

Net Margin (TTM)

ENSC-280.5%

INTS0.0%

FCF Margin (TTM)

ENSC-199.5%

INTSN/A

Net Income (TTM)

ENSC$-13M

INTS$-11M

FCF (TTM)

ENSC$-9M

INTS$-9M

EPS (TTM)

ENSC-$0.97

INTS-$4.12

ROE (TTM)

ENSC-37496.0%

INTS-11661.0%

ROA (TTM)

ENSC-32046.0%

INTS-9401.0%

ROIC (TTM)

ENSC-33277.0%

INTS-11661.0%

Cash

ENSC$677K

INTS$10M

Debt

ENSC$197K

INTS$0

Net Cash/Debt

ENSC$480K

INTS$10M

Current Ratio (TTM)

ENSC0.70x

INTS5.00x

Quick Ratio (TTM)

ENSC0.37x

INTS4.24x

Debt/Equity (TTM)

ENSC0.10x

INTS0.00x

Debt/Assets (TTM)

ENSC0.0%

INTS0.0%

Interest Coverage (TTM)

ENSCN/A

INTSN/A

Net Debt/EBITDA (TTM)

ENSC0.00x

INTS0.00x

Beta

ENSC1.10

INTS3.02

52W Performance

ENSC-78.6%

INTS-49.1%

YTD Performance

ENSC-43.9%

INTS-64.3%

% from 52W High

ENSC-80.8%

INTS-91.7%

% from 52W Low

ENSC129.1%

INTS13.1%

Asset Turnover (TTM)

ENSC1.14x

INTS0.00x

FCF Yield (TTM)

ENSC-116.0%

INTS-91.4%

Earnings Yield (TTM)

ENSC-163.1%

INTS-113.9%

Dividend Yield (TTM)

ENSCN/A

INTSN/A

Rule of 40

ENSC-238.8

INTS0.0

EV/GP/RG

ENSCN/A

INTSN/A

Ticker research

View ENSC research View INTS research

Metric	ENSC Ensysce Biosciences Inc	INTS Intensity Therapeutics Inc
Market & Valuation
Market Cap	$8M	$10M
Enterprise Value	$7M	$272K
Price	$0.53	$3.63
P/E Ratio	N/A	N/A
P/S Ratio	1.72x	0.00x
EV/Sales	1.61x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.39x	1.22x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.81x	-0.03x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$5M	$0
Revenue Growth (YoY)	-39.3%	N/A
Forward Rev Growth	-45.7%	506.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-197.8%	0.0%
Net Margin (TTM)	-280.5%	0.0%
FCF Margin (TTM)	-199.5%	N/A
Net Income (TTM)	$-13M	$-11M
FCF (TTM)	$-9M	$-9M
EPS (TTM)	-$0.97	-$4.12
ROE (TTM)	-37496.0%	-11661.0%
ROA (TTM)	-32046.0%	-9401.0%
ROIC (TTM)	-33277.0%	-11661.0%
Financial Health
Cash	$677K	$10M
Debt	$197K	$0
Net Cash/Debt	$480K	$10M
Current Ratio (TTM)	0.70x	5.00x
Quick Ratio (TTM)	0.37x	4.24x
Debt/Equity (TTM)	0.10x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.10	3.02
52W Performance	-78.6%	-49.1%
YTD Performance	-43.9%	-64.3%
% from 52W High	-80.8%	-91.7%
% from 52W Low	129.1%	13.1%
Efficiency & Yields
Asset Turnover (TTM)	1.14x	0.00x
FCF Yield (TTM)	-116.0%	-91.4%
Earnings Yield (TTM)	-163.1%	-113.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-238.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ENSC research	View INTS research

Valuation

P/S Ratio

INTS

0.00x

ENSC

1.72x

EV/FCF

ENSC

-0.81x

INTS

-0.03x

Growth & revenue

Revenue Growth TTM

ENSC

-39.3%

Forward Revenue Growth

INTS

506.0%

ENSC

-45.7%

Profitability & performance

Gross Margin

ENSC

0.0%

INTS

0.0%

ROE

INTS

-11661.0%

ENSC

-37496.0%

FCF Yield %

INTS

-91.4%

ENSC

-116.0%

52-Week Performance

INTS

-49.1%

ENSC

-78.6%

Detailed metrics comparison

ENSC

Ensysce Biosciences Inc

INTS

Intensity Therapeutics Inc

Market Cap

ENSC$8M

INTS$10M

Enterprise Value

ENSC$7M

INTS$272K

Price

ENSC$0.53

INTS$3.63

P/E Ratio

ENSCN/A

INTSN/A

P/S Ratio

ENSC1.72x

INTS0.00x

EV/Sales

ENSC1.61x

INTS0.00x

EV/EBITDA

ENSC0.00x

INTS0.00x

P/B Ratio

ENSC2.39x

INTS1.22x

P/FCF Ratio

ENSCN/A

INTSN/A

EV/FCF

ENSC-0.81x

INTS-0.03x

PEG Ratio

ENSCN/A

INTSN/A

Forward P/E (NTM)

ENSCN/A

INTSN/A

Forward P/S (NTM)

ENSCN/A

INTSN/A

Revenue (TTM)

ENSC$5M

INTS$0

Revenue Growth (YoY)

ENSC-39.3%

INTSN/A

Forward Rev Growth

ENSC-45.7%

INTS506.0%

Gross Margin (TTM)

ENSC0.0%

INTS0.0%

Operating Margin (TTM)

ENSC0.0%

INTS0.0%

EBITDA Margin (TTM)

ENSC-197.8%

INTS0.0%

Net Margin (TTM)

ENSC-280.5%

INTS0.0%

FCF Margin (TTM)

ENSC-199.5%

INTSN/A

Net Income (TTM)

ENSC$-13M

INTS$-11M

FCF (TTM)

ENSC$-9M

INTS$-9M

EPS (TTM)

ENSC-$0.97

INTS-$4.12

ROE (TTM)

ENSC-37496.0%

INTS-11661.0%

ROA (TTM)

ENSC-32046.0%

INTS-9401.0%

ROIC (TTM)

ENSC-33277.0%

INTS-11661.0%

Cash

ENSC$677K

INTS$10M

Debt

ENSC$197K

INTS$0

Net Cash/Debt

ENSC$480K

INTS$10M

Current Ratio (TTM)

ENSC0.70x

INTS5.00x

Quick Ratio (TTM)

ENSC0.37x

INTS4.24x

Debt/Equity (TTM)

ENSC0.10x

INTS0.00x

Debt/Assets (TTM)

ENSC0.0%

INTS0.0%

Interest Coverage (TTM)

ENSCN/A

INTSN/A

Net Debt/EBITDA (TTM)

ENSC0.00x

INTS0.00x

Beta

ENSC1.10

INTS3.02

52W Performance

ENSC-78.6%

INTS-49.1%

YTD Performance

ENSC-43.9%

INTS-64.3%

% from 52W High

ENSC-80.8%

INTS-91.7%

% from 52W Low

ENSC129.1%

INTS13.1%

Asset Turnover (TTM)

ENSC1.14x

INTS0.00x

FCF Yield (TTM)

ENSC-116.0%

INTS-91.4%

Earnings Yield (TTM)

ENSC-163.1%

INTS-113.9%

Dividend Yield (TTM)

ENSCN/A

INTSN/A

Rule of 40

ENSC-238.8

INTS0.0

EV/GP/RG

ENSCN/A

INTSN/A

Ticker research

View ENSC research View INTS research

Metric	ENSC Ensysce Biosciences Inc	INTS Intensity Therapeutics Inc
Market & Valuation
Market Cap	$8M	$10M
Enterprise Value	$7M	$272K
Price	$0.53	$3.63
P/E Ratio	N/A	N/A
P/S Ratio	1.72x	0.00x
EV/Sales	1.61x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.39x	1.22x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.81x	-0.03x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$5M	$0
Revenue Growth (YoY)	-39.3%	N/A
Forward Rev Growth	-45.7%	506.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-197.8%	0.0%
Net Margin (TTM)	-280.5%	0.0%
FCF Margin (TTM)	-199.5%	N/A
Net Income (TTM)	$-13M	$-11M
FCF (TTM)	$-9M	$-9M
EPS (TTM)	-$0.97	-$4.12
ROE (TTM)	-37496.0%	-11661.0%
ROA (TTM)	-32046.0%	-9401.0%
ROIC (TTM)	-33277.0%	-11661.0%
Financial Health
Cash	$677K	$10M
Debt	$197K	$0
Net Cash/Debt	$480K	$10M
Current Ratio (TTM)	0.70x	5.00x
Quick Ratio (TTM)	0.37x	4.24x
Debt/Equity (TTM)	0.10x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.10	3.02
52W Performance	-78.6%	-49.1%
YTD Performance	-43.9%	-64.3%
% from 52W High	-80.8%	-91.7%
% from 52W Low	129.1%	13.1%
Efficiency & Yields
Asset Turnover (TTM)	1.14x	0.00x
FCF Yield (TTM)	-116.0%	-91.4%
Earnings Yield (TTM)	-163.1%	-113.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-238.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ENSC research	View INTS research